Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Carbon, Maren
and
Correll, Christoph U.
2014.
Clinical predictors of therapeutic response to antipsychotics in schizophrenia.
Dialogues in Clinical Neuroscience,
Vol. 16,
Issue. 4,
p.
505.
DeVylder, Jordan E.
Muchomba, Felix M.
Gill, Kelly E.
Ben-David, Shelly
Walder, Deborah J.
Malaspina, Dolores
and
Corcoran, Cheryl M.
2014.
Symptom trajectories and psychosis onset in a clinical high-risk cohort: The relevance of subthreshold thought disorder.
Schizophrenia Research,
Vol. 159,
Issue. 2-3,
p.
278.
Levine, Stephen Z.
and
Leucht, Stefan
2014.
Treatment response heterogeneity in the predominant negative symptoms of schizophrenia: Analysis of amisulpride vs placebo in three clinical trials.
Schizophrenia Research,
Vol. 156,
Issue. 1,
p.
107.
Schubert, K Oliver
Clark, Scott R
and
Baune, Bernhard T
2015.
The use of clinical and biological characteristics to predict outcome following First Episode Psychosis.
Australian & New Zealand Journal of Psychiatry,
Vol. 49,
Issue. 1,
p.
24.
Vernal, Ditte L.
Kapoor, Sandeep
Al-Jadiri, Aseel
Sheridan, Eva M.
Borenstein, Yehonathan
Mormando, Charles
David, Lisa
Singh, Sukhbir
Seidman, Andrew J.
Carbon, Maren
Gerstenberg, Miriam
Saito, Ema
Kane, John M.
Steinhausen, Hans-Christoph
and
Correll, Christoph U.
2015.
Outcome of Youth with Early-Phase Schizophrenia-Spectrum Disorders and Psychosis Not Otherwise Specified Treated with Second-Generation Antipsychotics: 12 Week Results from a Prospective, Naturalistic Cohort Study.
Journal of Child and Adolescent Psychopharmacology,
Vol. 25,
Issue. 7,
p.
535.
de Leon, Jose
2015.
Is psychiatry only neurology? Or only abnormal psychology? Déjà vu after 100 years.
Acta Neuropsychiatrica,
Vol. 27,
Issue. 2,
p.
69.
Stentebjerg-Olesen, Marie
Ganocy, Stephen J.
Findling, Robert L.
Chang, Kiki
DelBello, Melissa P.
Kane, John M.
Tohen, Mauricio
Jeppesen, Pia
and
Correll, Christoph U.
2015.
Early response or nonresponse at week 2 and week 3 predict ultimate response or nonresponse in adolescents with schizophrenia treated with olanzapine: results from a 6-week randomized, placebo-controlled trial.
European Child & Adolescent Psychiatry,
Vol. 24,
Issue. 12,
p.
1485.
Birur, Badari
Thirthalli, Jagadisha
Janakiramaiah, N.
Shelton, Richard C.
and
Gangadhar, Bangalore N.
2016.
Dimensions of schizophrenia and their time course of response to a second generation antipsychotic olanzapine—A clinical study.
Asian Journal of Psychiatry,
Vol. 24,
Issue. ,
p.
17.
Bark, Nigel
Lawson, Nicholas
Trigoboff, Eileen
Varadi, Rodica
Grace, Jeffery
Olympia, Josie
Sindhu, Nighat
Watson, Tom
El-Defrawi, Mohamed
and
Roy, Punyabrata
2016.
Among the severely mentally ill, who responds to ziprasidone?.
Clinical Schizophrenia & Related Psychoses,
Abdin, Edimansyah
Chong, Siow Ann
Vaingankar, Janhavi Ajit
Peh, Chao Xu
Poon, Lye Yin
Rao, Sujatha
Verma, Swapna
Subramaniam, Mythily
and
Hashimoto, Kenji
2017.
Trajectories of positive, negative and general psychopathology symptoms in first episode psychosis and their relationship with functioning over a 2-year follow-up period.
PLOS ONE,
Vol. 12,
Issue. 11,
p.
e0187141.
Sami, Musa Basseer
and
Bhattacharyya, Sagnik
2018.
Are cannabis-using and non-using patients different groups? Towards understanding the neurobiology of cannabis use in psychotic disorders.
Journal of Psychopharmacology,
Vol. 32,
Issue. 8,
p.
825.
Hahn, Britta
2018.
The Potential of Cannabidiol Treatment for Cannabis Users With Recent-Onset Psychosis.
Schizophrenia Bulletin,
Vol. 44,
Issue. 1,
p.
46.
Lutgens, Danyael
Joober, Ridha
Iyer, Srividya
Lepage, Martin
Norman, Ross
Schmitz, Norbert
Mustafa, Sally
Abadi, Sherezad
and
Malla, Ashok
2019.
Progress of negative symptoms over the initial 5 years of a first episode of psychosis.
Psychological Medicine,
Vol. 49,
Issue. 1,
p.
66.
Bozzatello, Paola
Bellino, Silvio
and
Rocca, Paola
2019.
Predictive Factors of Treatment Resistance in First Episode of Psychosis: A Systematic Review.
Frontiers in Psychiatry,
Vol. 10,
Issue. ,
Roser, Patrik
2019.
Cannabis und Schizophrenie – Risikofaktoren, diagnostische Einordnung und Auswirkungen auf Verlauf und Prognose.
Forensische Psychiatrie, Psychologie, Kriminologie,
Vol. 13,
Issue. 3,
p.
225.
Chang, Wing Chung
Ho, Ryan Wui Hang
Tang, Jennifer Yee Man
Wong, Corine Sau Man
Hui, Christy Lai Ming
Chan, Sherry K W
Lee, Edwin M H
Suen, Yi Nam
and
Chen, Eric Y H
2019.
Early-Stage Negative Symptom Trajectories and Relationships With 13-Year Outcomes in First-Episode Nonaffective Psychosis.
Schizophrenia Bulletin,
Vol. 45,
Issue. 3,
p.
610.
Arsalan, Arsalan
Iqbal, Zafar
Tariq, Muhammad
Ayonrinde, Oyedeji
Vincent, John B.
and
Ayub, Muhammad
2019.
Association of smoked cannabis with treatment resistance in schizophrenia.
Psychiatry Research,
Vol. 278,
Issue. ,
p.
242.
Reid, Sam
and
Bhattacharyya, Sagnik
2019.
Antipsychotic treatment failure in patients with psychosis and co-morbid cannabis use: A systematic review.
Psychiatry Research,
Vol. 280,
Issue. ,
p.
112523.
Alisauskiene, Renata
Løberg, Else-Marie
Gjestad, Rolf
Kroken, Rune A.
Jørgensen, Hugo A.
and
Johnsen, Erik
2019.
The influence of substance use on the effectiveness of antipsychotic medication: a prospective, pragmatic study.
Nordic Journal of Psychiatry,
Vol. 73,
Issue. 4-5,
p.
281.
Quattrone, Diego
Di Forti, Marta
Gayer-Anderson, Charlotte
Ferraro, Laura
Jongsma, Hannah E
Tripoli, Giada
La Cascia, Caterina
La Barbera, Daniele
Tarricone, Ilaria
Berardi, Domenico
Szöke, Andrei
Arango, Celso
Lasalvia, Antonio
Tortelli, Andrea
Llorca, Pierre-Michel
de Haan, Lieuwe
Velthorst, Eva
Bobes, Julio
Bernardo, Miguel
Sanjuán, Julio
Santos, Jose Luis
Arrojo, Manuel
Del-Ben, Cristina Marta
Menezes, Paulo Rossi
Selten, Jean-Paul
Jones, Peter B
Kirkbride, James B
Richards, Alexander L
O'Donovan, Michael C
Sham, Pak C
Vassos, Evangelos
Rutten, Bart PF
van Os, Jim
Morgan, Craig
Lewis, Cathryn M
Murray, Robin M
and
Reininghaus, Ulrich
2019.
Transdiagnostic dimensions of psychopathology at first episode psychosis: findings from the multinational EU-GEI study.
Psychological Medicine,
Vol. 49,
Issue. 8,
p.
1378.